Shuguang Qin

Shuguang Qin

Auto-generated profile, based on publicly available information

Shuguang Qin

Institute of Sports and Exercise Biology, School of Physical Education Shaanxi Normal University Xi'an China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2024 in Acta Physiologica
Verified
Journal Article
Closed access
HLHangZhuo Li
HangZhuo Li
SQShuguang Qin
Shuguang Qin
JTJie Tang
Jie Tang
TWTao Wang
Tao Wang
WRWujing Ren
Wujing Ren
Zhenjun TianZhenjun Tian
Zhenjun Tian

16 January 2021 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SQShuguang Qin
Shuguang Qin
MBMaxime Boidin
Maxime Boidin
BBBen Buckley
Ben Buckley
Gregory LipGregory Lip
Gregory Lip
DTDick H. J. Thijssen
Dick H. J. Thijssen
Atrial fibrillation (AF) is the most common arrhythmia and is associated with worsened morbidity and mortality. The prevalence of AF is estimated to increase with an ageing population resulting in an ever‐increasing burden on the healthcare system. Despite improvements in AF treatment, several questions remain unanswered in relation to the development and progression of AF. In this review, we discuss the evidence supporting the presence of vascular dysfunction in the development of AF, but also as a final common pathway explaining why AF constitutes a markedly increased risk of cardiovascular morbidity and mortality. Specifically, we summarise the work performed in humans related to the impact of AF on vascular structure and function, and whether measures of vascular function predict AF progression and the development of cardiovascular events. Subsequently, we discuss the potential mechanisms linking AF to the development of vascular dysfunction. Finally, we propose future perspectives of vascular health and AF, advocating a strong focus on regular exercise training as a safe and effective strategy to improve vascular function and, hence, reduce the risk for development and progression of AF and its associated risk for cardiovascular events.